Whole-body PBPK model of NMN as MATE1 and OCT2 biomarker
Within this repository, we distribute a whole-body PBPK model of NMN, that has been carefully developed using a large number of clinical studies and evaluated within our drug-biomarker interaction modeling network. The model applies endogenous synthesis in liver cells, metabolism via AOX1, active tubular secretion via OCT2 and MATE1, active tubular reabsorption as well as diurnal variation.
The MoBi project file contains simulations of clinical studies utilized during model establishment, including the respective observed data [1][2][3]. For further details, quantitative model evaluation, sensitivity analysis and extensive documentation please refer to [4].
MoBi Version 9.1
Everyone interacting in the Open Systems Pharmacology community (codebases, issue trackers, chat rooms, mailing lists etc...) is expected to follow the Open Systems Pharmacology code of conduct.
We encourage contribution to the Open Systems Pharmacology community. Before getting started please read the contribution guidelines. If you are contributing code, please be familiar with the coding standard.
The model code is distributed under the GPLv2 License.